Back to Search
MICHAEL SEIDEN, MD
MD
Medical Oncology Physician
NPI: 1760464705Individual
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
71183(MA)
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
71183(MA)MD432386(PA)P8997(TX)
Research & Publications (20)
Risk stratification for desensitization of patients with carboplatin hypersensitivity: clinical presentation and management.
PMID 19501233·J Allergy Clin Immunol·2009
8-other
CDDO-Me, a synthetic triterpenoid, inhibits expression of IL-6 and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells.
PMID 18587580·Cancer Chemother Pharmacol·2009
8-other
Functional analyses of the cancer stem cell-like properties of human endometrial tumor initiating cells.
PMID 18256549·Cell Cycle·2008
7-preclinical
Modulation of drug resistance in ovarian adenocarcinoma by enhancing intracellular ceramide using tamoxifen-loaded biodegradable polymeric nanoparticles.
PMID 18483388·Clin Cancer Res·2008
7-preclinical
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients.
PMID 18287062·Proc Natl Acad Sci U S A·2008
3-trial
Mechanisms of Cables 1 gene inactivation in human ovarian cancer development.
PMID 18059193·Cancer Biol Ther·2008
8-other
Pooling of case specimens to create standard serum sets for screening cancer biomarkers.
PMID 17301268·Cancer Epidemiol Biomarkers Prev·2007
8-other
Decreased intraperitoneal disease recurrence in epithelial ovarian cancer patients receiving intraperitoneal consolidation treatment with yttrium-90-labeled murine HMFG1 without improvement in overall survival.
PMID 17354223·Int J Cancer·2007
3-trial
Case records of the Massachusetts General Hospital. Case 13-2007. A 46-year-old woman with gynecologic and intestinal cancers.
PMID 17460231·N Engl J Med·2007
5-case
Modulation of intracellular ceramide using polymeric nanoparticles to overcome multidrug resistance in cancer.
PMID 17510414·Cancer Res·2007
8-other
Paclitaxel and ceramide co-administration in biodegradable polymeric nanoparticulate delivery system to overcome drug resistance in ovarian cancer.
PMID 17557285·Int J Cancer·2007
4-observational
Phase II study of intraperitoneal recombinant interleukin-12 (rhIL-12) in patients with peritoneal carcinomatosis (residual disease < 1 cm) associated with ovarian cancer or primary peritoneal carcinoma.
PMID 18076766·J Transl Med·2007
3-trial
Phase I clinical trial of STA-4783 in combination with paclitaxel in patients with refractory solid tumors.
PMID 17255281·Clin Cancer Res·2007
3-trial
A phase II trial of EMD72000 (matuzumab), a humanized anti-EGFR monoclonal antibody, in patients with platinum-resistant ovarian and primary peritoneal malignancies.
PMID 17126894·Gynecol Oncol·2007
3-trial
Demographic, risk factor, and knowledge differences between Latinas and non-Latinas referred to colposcopy.
PMID 16949138·Gynecol Oncol·2007
8-other
8-benzyl-4-oxo-8-azabicyclo[3.2.1]oct-2-ene-6,7-dicarboxylic acid (SD-1008), a novel janus kinase 2 inhibitor, increases chemotherapy sensitivity in human ovarian cancer cells.
PMID 17675586·Mol Pharmacol·2007
8-other
SD-1029 inhibits signal transducer and activator of transcription 3 nuclear translocation.
PMID 17121906·Clin Cancer Res·2006
7-preclinical
Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer.
PMID 16951221·Clin Cancer Res·2006
8-other
Mullerian Inhibiting Substance enhances subclinical doses of chemotherapeutic agents to inhibit human and mouse ovarian cancer.
PMID 17088539·Proc Natl Acad Sci U S A·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 9200 PINECROFT DR STE 450
SHENANDOAH, TX 77380 - Phone
- (281) 296-0365
Quick Facts
- NPI
- 1760464705
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 4
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile